Isosorbide Mononitrate is used for the treatment of Angina (heart-related chest pain)
🛒 How to order this item?
It is unsafe to consume alcohol while taking A-Card 20mg Tablet. Drinking alcohol with this medication may lead to symptoms such as flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure (Disulfiram reaction).
Using A-Card 20mg Tablet during pregnancy may be unsafe. While there are limited human studies, animal research has indicated potential harm to the developing baby. Your doctor will evaluate the benefits and potential risks before prescribing this medication during pregnancy. It's advisable to consult your doctor.
A-Card 20mg Tablet is likely safe to use while breastfeeding. Limited human data suggests that the drug does not pose a significant risk to the baby. If you have concerns, consult your doctor before using this medication while breastfeeding.
A-Card 20mg Tablet may reduce alertness, affect your vision, or cause drowsiness and dizziness. If you experience these symptoms, it is unsafe to drive. Avoid operating a vehicle or heavy machinery if you encounter these side effects.
A-Card 20mg Tablet is safe to use in patients with kidney disease. No dose adjustment is typically required for individuals with kidney issues. However, if you have underlying kidney problems, it's advisable to discuss your condition with your doctor.
A Card is probably safe for patients with liver disease. The available data indicates that dose adjustment is generally not necessary for individuals with liver issues. Nevertheless, it's essential to consult your doctor, especially if you have liver disease.
It works by reducing the heart's workload and decreasing the demand for blood and oxygen supply to the heart muscle.
Common side effects may include headache, dizziness, and hypotension.
Isosorbide Mononitrate is used to prevent and treat angina pectoris caused by coronary artery disease. It is not effective in stopping an acute anginal attack due to its slow onset of action.
Isosorbide mononitrate is the primary active metabolite of isosorbide dinitrate (ISDN), and most of the clinical effects of the dinitrate are attributed to the mononitrate. Its pharmacological action primarily involves the relaxation of vascular smooth muscle and subsequent dilation of peripheral arteries and veins, particularly veins. Dilation of veins promotes peripheral blood pooling and reduces venous return to the heart, thereby reducing left ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload). Arteriolar relaxation decreases systemic vascular resistance, systolic arterial pressure, and mean arterial pressure (afterload). It also results in dilation of the coronary arteries. The relative significance of preload reduction, afterload reduction, and coronary dilation remains unclear.
Tablet: The usual oral dose is one tablet (20 mg) taken twice daily, with the first dose in the morning and the second dose 7 hours later. While maintenance doses can range from 20 mg to 120 mg (1-6 tablets), a starting dose of 10 mg (1/2 tablet) is suitable when commencing treatment or as directed by a registered physician.
Sustained Release Capsule: The usual oral dose is one capsule (50 mg) taken daily or as directed by a registered physician.
Protect from light and moisture by storing below 30°C. Keep the medicine out of children's reach.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.